Interestingly, previous studies have already observed a correlation between NTSR3/sortilin expression and malignancy as characterized in glioma where the increase in the expression of NTSR3/sortilin was positively correlated with the malignancy of the tumor [26]. This evidence concerns the gene SORT1 and central nervous system cancer.